Table 4.
One-year BP control for main drug uses in hypertensive populations with compliance
| Number of patients with compliance
|
Number (%) of patients with BP control
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rushan | Taixing | Yuhu | Wuhou | Total | Rushan | Taixing | Yuhu | Wuhou | Total | |
| CCB | 2,588 | 5,257 | 16,243 | 2,928 | 27,016 | 947 (36.6) | 2,043 (38.9) | 10,966 (67.5) | 2,489 (85.0) | 16,445 (60.9) |
| Diuretics | 725 | 132 | 1,504 | 132 | 2,493 | 302 (41.7) | 49 (37.1) | 1,141 (75.9) | 119 (90.2) | 1,611 (64.6) |
| BB | 145 | 175 | 567 | 173 | 1,060 | 64 (44.1) | 69 (39.4) | 374 (66.0) | 156 (90.2) | 663 (62.6) |
| ACEI | 1,613 | 9,735 | 3,221 | 615 | 15,184 | 590 (36.6) | 3,527 (36.2) | 2,147 (66.7) | 562 (91.4) | 6,826 (45.0) |
| ARB | 388 | 231 | 656 | 217 | 1,492 | 140 (36.1) | 91 (39.4) | 440 (67.1) | 183 (84.3) | 854 (57.2) |
| S1 | 0 | 4,596 | 1,074 | 3 | 5,673 | 0 | 1,666 (36.3) | 711 (66.2) | 3 (100.0) | 2,380 (42.0) |
| C1 | 1,027 | 2,000 | 350 | 674 | 4,051 | 296 (28.8) | 518 (25.9) | 171 (48.9) | 607 (90.1) | 1,592 (39.3) |
| S2 | 2,362 | 17,849 | 4,372 | 225 | 24,808 | 931 (39.4) | 6,514 (36.5) | 2,562 (58.6) | 198 (88.0) | 10,205 (41.1) |
Notes: No patients persisted with multiple-pill combination of non-first-line drugs. S1, fixed-dose single-pill combinations only including first-line drugs; S2, single-pill combinations including both first-line and non-first-line drugs; C1, multiple-pill combination of frst-line drugs.
Abbreviations: ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; BB, beta-blocker; BP, blood pressure; CCB, calcium channel antagonist.